News & Views | Published:

Muscling in on rhabdomyosarcoma

Nature Medicine volume 8, pages 12001201 (2002) | Download Citation


A poorly understood cancer of childhood has just become less mysterious. A new animal model identifies three pathways that underlie the progression to rhabdomyosarcoma (pages 1276–1280).

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    & Soft Tissue Tumors. 3rd. edn (C.V. Mosby, St. Louis, 2000).

  2. 2.

    et al. Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis. Nature Med. 8, 1276–1280 (2002).

  3. 3.

    et al. Muscle-specific gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development. Cancer Res. 51, 5100–5106 (1991).

  4. 4.

    et al. Homozygous deletion frequency and expression levels of the CDKN2A gene in human sarcomas—relationship to amplification and mRNA levels. Br. J. Cancer 72, 393–398 (1995).

  5. 5.

    et al. Mechanisms of p53 loss in human sarcomas. Proc. Natl. Acad. Sci. USA 87, 5863–5867 (1990).

  6. 6.

    & Rhabdomyosarcoma—working out the pathways. Oncogene 12, 1697–1705 (1996).

  7. 7.

    et al. Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcoma. Oncogene 12, 1697–1705 (1996).

  8. 8.

    et al. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc. Natl. Acad. Sci. USA 94, 701–706 (1997).

  9. 9.

    et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27–37 (1996).

Download references

Author information


  1. Ludwig Institute for Cancer Research Department of Medicine, Cancer Center and Center for Molecular Genetics University of California at San Diego La Jolla, California, USA

    • Webster K. Cavenee


  1. Search for Webster K. Cavenee in:

About this article

Publication history



Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing